Sarah Corsi

Sarah Corsi, PhD has a diverse background in scientific research and academia. Sarah is currently working as a Research Scientist at Oxford Nanopore Technologies since March 2022. Previously, they worked for Public Health England as a Specialist Healthcare Scientist from April 2020 to February 2022.

Before joining Public Health England, Sarah was a PhD Student at Newcastle University from September 2016 to September 2020. During this time, they published articles related to their research.

Sarah's academic journey started at The University of Bonn, where they pursued a Master's degree in Neuroscience from September 2014 to September 2016. Sarah'sthesis project focused on the degradation of linear mtDNA. Prior to that, they completed an MSc in Biomedical Science at the University of Strathclyde from September 2013 to September 2014.

Furthermore, Sarah gained valuable experience at Novartis as a BSc Thesis Project Intern from January 2013 to September 2013. Sarah'sresearch project involved investigating the nuclear localization of PIM3, a protein associated with pancreatic cancer.

Overall, Sarah Corsi has demonstrated expertise in scientific research and has made significant contributions to their field through publications and industry experience.

Sarah Corsi, PhD has a strong educational background in the field of science. Sarah completed their Doctor of Philosophy (PhD) degree at Newcastle University from 2016 to 2020, but their specific field of study is not provided. Prior to this, they obtained a Master's Degree in Neuroscience from The University of Bonn from 2014 to 2016. In 2013 to 2014, they pursued another Master's Degree in MSc Biomedical Science at the University of Strathclyde. Sarah's educational journey began with a Bachelor's Degree in Scienze Biologice (BSc Biological Science) from Università degli Studi di Siena, where they studied from 2010 to 2013.

Additionally, Sarah has obtained a certification in "How to Be Both Assertive and Likable" from LinkedIn in August 2022.